Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 0 Non-interventional, Multi-center, Natural History Study in Pediatric Patients with Syntaxin Binding Protein 1 (STXBP1) Encephalopathy with Epilepsy

NCT05462054 is registered in ClinicalTrials.gov with Capsida Biotherapeutics, Inc. as lead sponsor.

NCT NCT05462054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05462054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 0 Non-interventional, Multi-center, Natural History Study in Pediatric Patients with Syntaxin Binding Protein 1 (STXBP1) Encephalopathy with Epilepsy
Lead sponsor
Capsida Biotherapeutics, Inc.
Phase
Observational
Overall status
Withdrawn
Start date
October 31, 2024
Completion date
January 31, 2026
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stxbp1 encephalopathy with epilepsy